The expression of PRDX1 was significantly elevated in BRCA tissues, particularly in monocytes, indicating that PRDX1 may play a pivotal role in the BRCA-associated immune microenvironment (De Leo et al., 2024). Here, PRDX1 is linked to invasive breast carcinoma.